Bausch Health (BHC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BHC Bausch Health

Watchlist

7.970
-0.210-2.57%

Close Nov 22 16:00 ET

8.010
+0.040+0.50%

Post 19:43 ET

2.93BMarket Cap-16604P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Bausch Health Announces CABTREO Receives Positive Reimbursement Recommendations
TipRanksNov 18 08:55 ET
PrCABTREOTM (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations From Canada's Drug Agency and Quebec's INESSS
AccesswireNov 18 08:00 ET
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
AccesswireNov 18 08:00 ET
US Manufacturing Index Rises To 43, Highest Since 2020
Business TodayNov 16 02:13 ET
Express News | Icahn Enterprises Discloses 9% Ownership Stake in Bausch Health Companies as of Sept 30 - Presentation
ReutersNov 12 09:43 ET
Alembic Pharmaceuticals Gets Final US FDA Nod for Diltiazem Hydrochloride Capsules
MT NewswiresNov 11 02:11 ET

Comments

Stock Region

Jul 24 18:51

Health Company Responds To False Rumors Over Bankruptcy Consideration

Bausch Health Responds to Market Rumors.
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) recently found itself at the center of market rumors that suggested the company was considering bankruptcy or insolvency proceedings. These rumors originated from an article issued by Reorg®, citing unnamed sources. In response, Bausch Health has categorically denied these claims, emphasizing that they are unsubstantiated and without merit...

Mcsnacks H Tupack

Jul 24 12:16

Refutes claim

$Bausch Health (BHC.US)$ See you at 8.00.

Moomoo AI

Jun 22 08:31

Bausch Health's revenue growth is unimpressive due to its lack of profitability. The share price crash may be an over-reaction, but improvements in business fundamentals are needed before considering a purchase. The company's long-term performance is concerning, and clear growth indicators are required for share price stability.

Strong Week for Bausch Health Companies (NYSE:BHC) Shareholders Doesn't Alleviate Pain of Three-year Loss

Options Newsman

Apr 5 20:47

Columns Options Market Statistics: TSLA Shares Fall and Options Pop as Reports Suggest the Company Scraps Low-cost Car Plans

News Highlights
$Tesla (TSLA.US)$ shares fell by 3.63%, closing at $164.90. Its options trading volume was 3.83 million. Call contracts account for 48.3% of the total trading volume. The most traded calls are contracts of $170 strike price that expire on Apr. 5th. The total volume reaches 106,470 with an open interest of 29,026. The most traded puts are contracts of a $165 strike p...

Meltyy

Feb 21 21:25

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions (EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

BHC Bausch Health

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target